share_log
Moomoo 24/7 ·  Apr 11 08:31
Leap Therapeutics Inc: Intends to Use Net Proceeds From Financing to Fund Continued Development of Its Lead Monoclonal Antibody Program, Dkn-01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment